BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 290.10
-6.30 (-2.13%)
Oct 1, 2026, 2:24 PM IDT
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 26.34 million as of October 2, 2026. Its market cap has decreased by -31.37% in one year.
Market Cap
26.34M
Enterprise Value
14.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
290.10
ChartMarket Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 26.34M, a decrease of -44.83%. That is a compound annual growth rate of -2.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 26.34M | -17.25% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 77.30M |
| BioLineRx | 38.83M |
| Clal Biotechnology Industries | 37.96M |
| Purple Biotech | 32.42M |
| XTL Biopharmaceuticals | 25.16M |
| Can-Fite BioPharma | 20.06M |
| Evogene | 19.51M |